Cargando…
Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production
BACKGROUND: Whole-cell redox biocatalysis has been intensively explored for the production of valuable compounds because excellent selectivity is routinely achieved. Although the cellular cofactor level, redox state and the corresponding enzymatic activity are expected to have major effects on the p...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831814/ https://www.ncbi.nlm.nih.gov/pubmed/24209782 http://dx.doi.org/10.1186/1475-2859-12-103 |
_version_ | 1782291621813944320 |
---|---|
author | Zhou, Yongjin J Yang, Wei Wang, Lei Zhu, Zhiwei Zhang, Sufang Zhao, Zongbao K |
author_facet | Zhou, Yongjin J Yang, Wei Wang, Lei Zhu, Zhiwei Zhang, Sufang Zhao, Zongbao K |
author_sort | Zhou, Yongjin J |
collection | PubMed |
description | BACKGROUND: Whole-cell redox biocatalysis has been intensively explored for the production of valuable compounds because excellent selectivity is routinely achieved. Although the cellular cofactor level, redox state and the corresponding enzymatic activity are expected to have major effects on the performance of the biocatalysts, our ability remains limited to predict the outcome upon variation of those factors as well as the relationship among them. RESULTS: In order to investigate the effects of cofactor availability on whole-cell redox biocatalysis, we devised recombinant Escherichia coli strains for the production of dihydroxyacetone (DHA) catalyzed by the NAD(+)-dependent glycerol dehydrogenase (GldA). In this model system, a water-forming NAD(+) oxidase (NOX) and a NAD(+) transporter (NTT4) were also co-expressed for cofactor regeneration and extracellular NAD(+) uptake, respectively. We found that cellular cofactor level, NAD(+)/NADH ratio and NOX activity were not only strain-dependent, but also growth condition-dependent, leading to significant differences in specific DHA titer among different whole-cell biocatalysts. The host E. coli DH5α had the highest DHA specific titer of 0.81 g/g(DCW) with the highest NAD(+)/NADH ratio of 6.7 and NOX activity of 3900 U. The biocatalyst had a higher activity when induced with IPTG at 37°C for 8 h compared with those at 30°C for 8 h and 18 h. When cells were transformed with the ntt4 gene, feeding NAD(+) during the cell culture stage increased cellular NAD(H) level by 1.44 fold and DHA specific titer by 1.58 fold to 2.13 g/g(DCW). Supplementing NAD(+) during the biotransformation stage was also beneficial to cellular NAD(H) level and DHA production, and the highest DHA productivity reached 0.76 g/g(DCW)/h. Cellular NAD(H) level, NAD(+)/NADH ratio, and NOX and GldA activity dropped over time during the biotransformation process. CONCLUSIONS: High NAD(+)/NADH ratio driving by NOX was very important for DHA production. Once cofactor was efficiently cycled, high cellular NAD(H) level was also beneficial for whole-cell redox biocatalysis. Our results indicated that NAD(+) transporter could be applied to manipulate redox cofactor level for biocatalysis. Moreover, we suggested that genetically designed redox transformation should be carefully profiled for further optimizing whole-cell biocatalysis. |
format | Online Article Text |
id | pubmed-3831814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38318142013-11-19 Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production Zhou, Yongjin J Yang, Wei Wang, Lei Zhu, Zhiwei Zhang, Sufang Zhao, Zongbao K Microb Cell Fact Research BACKGROUND: Whole-cell redox biocatalysis has been intensively explored for the production of valuable compounds because excellent selectivity is routinely achieved. Although the cellular cofactor level, redox state and the corresponding enzymatic activity are expected to have major effects on the performance of the biocatalysts, our ability remains limited to predict the outcome upon variation of those factors as well as the relationship among them. RESULTS: In order to investigate the effects of cofactor availability on whole-cell redox biocatalysis, we devised recombinant Escherichia coli strains for the production of dihydroxyacetone (DHA) catalyzed by the NAD(+)-dependent glycerol dehydrogenase (GldA). In this model system, a water-forming NAD(+) oxidase (NOX) and a NAD(+) transporter (NTT4) were also co-expressed for cofactor regeneration and extracellular NAD(+) uptake, respectively. We found that cellular cofactor level, NAD(+)/NADH ratio and NOX activity were not only strain-dependent, but also growth condition-dependent, leading to significant differences in specific DHA titer among different whole-cell biocatalysts. The host E. coli DH5α had the highest DHA specific titer of 0.81 g/g(DCW) with the highest NAD(+)/NADH ratio of 6.7 and NOX activity of 3900 U. The biocatalyst had a higher activity when induced with IPTG at 37°C for 8 h compared with those at 30°C for 8 h and 18 h. When cells were transformed with the ntt4 gene, feeding NAD(+) during the cell culture stage increased cellular NAD(H) level by 1.44 fold and DHA specific titer by 1.58 fold to 2.13 g/g(DCW). Supplementing NAD(+) during the biotransformation stage was also beneficial to cellular NAD(H) level and DHA production, and the highest DHA productivity reached 0.76 g/g(DCW)/h. Cellular NAD(H) level, NAD(+)/NADH ratio, and NOX and GldA activity dropped over time during the biotransformation process. CONCLUSIONS: High NAD(+)/NADH ratio driving by NOX was very important for DHA production. Once cofactor was efficiently cycled, high cellular NAD(H) level was also beneficial for whole-cell redox biocatalysis. Our results indicated that NAD(+) transporter could be applied to manipulate redox cofactor level for biocatalysis. Moreover, we suggested that genetically designed redox transformation should be carefully profiled for further optimizing whole-cell biocatalysis. BioMed Central 2013-11-09 /pmc/articles/PMC3831814/ /pubmed/24209782 http://dx.doi.org/10.1186/1475-2859-12-103 Text en Copyright © 2013 Zhou et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Zhou, Yongjin J Yang, Wei Wang, Lei Zhu, Zhiwei Zhang, Sufang Zhao, Zongbao K Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production |
title | Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production |
title_full | Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production |
title_fullStr | Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production |
title_full_unstemmed | Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production |
title_short | Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production |
title_sort | engineering nad(+) availability for escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831814/ https://www.ncbi.nlm.nih.gov/pubmed/24209782 http://dx.doi.org/10.1186/1475-2859-12-103 |
work_keys_str_mv | AT zhouyongjinj engineeringnadavailabilityforescherichiacoliwholecellbiocatalysisacasestudyfordihydroxyacetoneproduction AT yangwei engineeringnadavailabilityforescherichiacoliwholecellbiocatalysisacasestudyfordihydroxyacetoneproduction AT wanglei engineeringnadavailabilityforescherichiacoliwholecellbiocatalysisacasestudyfordihydroxyacetoneproduction AT zhuzhiwei engineeringnadavailabilityforescherichiacoliwholecellbiocatalysisacasestudyfordihydroxyacetoneproduction AT zhangsufang engineeringnadavailabilityforescherichiacoliwholecellbiocatalysisacasestudyfordihydroxyacetoneproduction AT zhaozongbaok engineeringnadavailabilityforescherichiacoliwholecellbiocatalysisacasestudyfordihydroxyacetoneproduction |